Corporate Site
Skip to main content
Home
Corporate Profile
News Releases
Events & Presentations
Events Calendar
Presentations
Archived Events & Presentation
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Fundamentals
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Beckman Litigation
Cautionary Information
Coronavirus
News Releases
Home
Corporate Profile
News Releases
Events & Presentations
Events Calendar
Presentations
Archived Events & Presentation
Stock Information
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Fundamentals
Financials
Quarterly Results
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Beckman Litigation
Cautionary Information
Coronavirus
Corporate Site
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2021
2020
2019
2018
2017
2016
2015
2014
06/11/2021
Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device
06/10/2021
Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
05/24/2021
Quidel to Present Virtually at William Blair 41st Annual Growth Stock Conference
05/24/2021
Health Canada Approves Quidel’s Sofia® SARS Antigen FIA Test for Screening of Asymptomatic Populations With Serial Testing
05/14/2021
Quidel’s QuickVue® At-Home OTC COVID-19 Test Now Available for Sale Through Amazon
05/06/2021
Quidel Reports First Quarter 2021 Financial Results
05/05/2021
Quidel Forms Retail Collaboration With Walgreens for Over-the-Counter Sale of QuickVue® At-Home OTC COVID-19 Tests
05/04/2021
Quidel to Present Virtually at the BofA Securities 2021 Health Care Conference
04/27/2021
Teaching Doctors Nationwide How to Recognize and Differentiate Between Lyme Disease, COVID-19 and the Flu in Quidel-Hosted May 5 Webinar
04/26/2021
Quidel to Hold Fiscal First Quarter 2021 Financial Results Conference Call on May 6th, 2021
04/22/2021
Quidel Signs Retail Distribution Agreement to Increase Access to At-Home COVID-19 Testing
04/22/2021
Quidel Announces Preliminary Revenue for First Quarter 2021
04/13/2021
Quidel Corporation Partners With the Bay Area Lyme Foundation to Heighten Public Awareness of Lyme Disease
04/05/2021
Start of Lyme Disease Season Provides Heightened Risks for Americans Wanting to Go Outdoors After a Year of COVID-19 Restrictions
04/01/2021
Quidel’s Sofia® SARS Antigen Test Receives Emergency Use Authorization for Screening Use With Serial Testing
04/01/2021
Quidel Partners With San Diego Padres Organization for COVID-19 Testing
03/31/2021
Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing
03/31/2021
Quidel’s QuickVue® At-Home OTC COVID-19 Test Receives Emergency Use Authorization for Screening Use With Serial Testing
03/18/2021
Quidel Corporation Applauds Biden Administration Plan to Expand COVID-19 Testing
03/01/2021
Quidel Receives Emergency Use Authorization for QuickVue® At-Home COVID-19 Test
02/22/2021
Quidel to Present at Upcoming Conferences
02/18/2021
Quidel Reports Fourth Quarter and Full Year 2020 Financial Results
02/03/2021
Quidel Opens New Manufacturing Facility to Mass Produce QuickVue® Rapid Antigen Tests for COVID-19
01/28/2021
Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021
01/07/2021
Quidel Announces Preliminary Revenue for Fourth Quarter 2020; Will Present Virtually at 39th Annual J.P. Morgan Healthcare Conference